Researcher
Omar Ali, PhD
Harvard University (formerly)
Lyell Immunopharma
Education:
Harvard University, PhD, Bioengineering
University of Michigan, MSE, Bioengineering
University of Minnesota, BS, Chemical Engineering
Research Focus:
As a scientist at the Wyss Institute at Harvard University, Dr. Ali utilized material platforms to study the development of cancer immunity, specifically as it pertains to melanoma. His research focused on the design of cancer vaccines, utilizing immunologically active biomaterials. His research investigated the importance of incorporating various immune cells within cancer vaccination protocols. His goal was to begin identifying a cellular and molecular blueprint of a successful melanoma cancer vaccine.